Prehliadač alebo jeho nastavenia nie sú podporované.

Praktik.ai používa moderné webové technológie kvôli bezpečnosti, rýchlosti a spoľahlivému prihlasovaniu. Tento prehliadač ich nepodporuje alebo blokuje JavaScript, preto sa aplikácia nemusí správne načítať.

Aktualizujte prosím Chrome, Edge, Firefox alebo Safari na najnovšiu verziu a stránku potom obnovte.

Ak používate Windows 7, Windows 8 alebo Windows 8.1, Chrome a Edge už nemusia ponúkať novú verziu. V takom prípade použite novšie zariadenie alebo kontaktujte podporu Praktik.ai.

Prohlížeč nebo jeho nastavení nejsou podporované.

Praktik.ai používá moderní webové technologie kvůli bezpečnosti, rychlosti a spolehlivému přihlašování. Tento prohlížeč je nepodporuje nebo blokuje JavaScript, proto se aplikace nemusí správně načíst.

Aktualizujte prosím Chrome, Edge, Firefox nebo Safari na nejnovější verzi a stránku potom obnovte.

Pokud používáte Windows 7, Windows 8 nebo Windows 8.1, Chrome a Edge už nemusí nabízet novou verzi. V takovém případě použijte novější zařízení nebo kontaktujte podporu Praktik.ai.

Your browser or its settings are not supported.

Praktik.ai uses modern web technologies for security, speed, and reliable sign-in. This browser does not support them, or JavaScript is blocked, so the app may not load correctly.

Please update Chrome, Edge, Firefox, or Safari to the latest version and then reload this page.

If you use Windows 7, Windows 8, or Windows 8.1, Chrome and Edge may no longer offer a newer version. In that case, use a newer device or contact Praktik.ai support.

Effective COMMISSION IMPLEMENTING DECISION (EU) 2026/1112 of 22 May 2026 not renewing the approval of cypermethrin for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)

Rozhodnutie č. 1112/2026

Text language

Important dates

Declared: 22. mája 2026
Approved: 22. mája 2026
Effective from: 15. júna 2026

Documents and links

COMMISSION IMPLEMENTING DECISION (EU) 2026/1112

of 22 May 2026

not renewing the approval of cypermethrin for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (1), and in particular Article 14(4), first subparagraph, point (b), thereof,

Whereas:

(1)

Cypermethrin was approved as an active substance for use in biocidal products of product-type 8 by Commission Implementing Regulation (EU) No 945/2013 (2) subject to the conditions set out in the Annex to that Regulation.

(2)

The approval of cypermethrin for use in biocidal products of product-type 8 (‘the approval’) was to expire on 31 May 2025. On 24 November 2023, an application was submitted in accordance with Article 13(1) of Regulation (EU) No 528/2012 for the renewal of the approval.

(3)

Commission Implementing Decision (EU) 2025/362 (3) postponed the expiry date of the approval to 30 November 2027 in order to allow sufficient time for the examination of the application for renewal.

(4)

However, on 21 May 2025, the applicant who submitted the initial application informed the Commission that it withdrew its application for the renewal of the approval. Consequently, as it has not been established that cypermethrin still meets the conditions laid down in Article 4(1) of Regulation (EU) No 528/2012, it is appropriate to not renew the approval.

(5)

In order to allow sufficient time for economic operators to adapt, treated articles treated with or incorporating cypermethrin for use in biocidal products of product-type 8 may be placed on the market for a period of 180 days after the entry into force of this Decision.

(6)

The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Biocidal Products,

HAS ADOPTED THIS DECISION:

Article 1

The approval of cypermethrin as an active substance for use in biocidal products of product-type 8 is not renewed.

Article 2

Treated articles treated with or intentionally incorporating cypermethrin for wood preservation shall no longer be placed on the market as from 22 December 2026.

Article 3

This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Done at Brussels, 22 May 2026.

For the Commission

The President

Ursula VON DER LEYEN

Poznámky

(2)  Commission Implementing Regulation (EU) No 945/2013 of 2 October 2013 approving cypermethrin as an existing active substance for use in biocidal products for product-type 8 (OJ L 261, 3.10.2013, p. 23, ELI: http://data.europa.eu/eli/reg_impl/2013/945/oj).

(3)  Commission Implementing Decision (EU) 2025/362 of 21 February 2025 postponing the expiry date of the approval of cypermethrin for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2025/362, 24.2.2025, ELI: http://data.europa.eu/eli/dec_impl/2025/362/oj).